Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

69.29 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 69.29
Bid (Size) 63.39 (1)
Ask (Size) 80.00 (1)
Prev. Close 69.29
Today's Range 69.29 - 69.29
52wk Range 32.86 - 93.66
Shares Outstanding 104,084,876
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Arrowhead receives breakthrough therapy designation for ARO-AAT and announces full enrollment for SEQUOIA Phase 2 clinical trial 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Third Quarter Results
Arrowhead host a webcast and conference call on August 5, 2021, at 4:30 p.m. ET to discuss fiscal 2021 third quarter results 
From Business Wire News Releases

Performance

YTD
-7.40%
-7.40%
1 Month
+9.76%
+9.76%
3 Month
-1.35%
-1.35%
6 Month
-13.13%
-13.13%
1 Year
+56.13%
+56.13%

More News

Read More
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Business Wire News Releases
Arrowhead Announces Positive Interim Results from Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
From Business Wire News Releases
First Week of March 2022 Options Trading For Arrowhead Pharmaceuticals
Tags Stocks
From Market News Video
Russell 2000 Traders Place Bearish Bets Via IWM ETF
Tags Top Stories OVV CROX
From Benzinga
Arrowhead's Big Sell-Off Presents Buying Opportunity, According to HC Wainwright
Tags Price Target Analyst Color Analyst Ratings
From Benzinga
IWM, NTLA, ARWR, LSCC: ETF Outflow Alert
Tags ETFs
From ETF Channel
Arrowhead Pharmaceuticals: Buy the Dip?
Tags TKPHF Market News ARWR
From Motley Fool
Arrowhead's ARO-HIF2 Shows Early Signs Of Efficacy In Type Of Kidney Cancer
Tags Briefs News Kidney Cancer
From Benzinga
Noteworthy Friday Option Activity: OPRX, ARWR, TWOU
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.